- Home
- MOGU vs AYTU Comparison
MOGU vs AYTU Comparison
Compare MOGU & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGU
- AYTU
- Stock Information
- Founded
- MOGU 2011
- AYTU N/A
- Country
- MOGU China
- AYTU United States
- Employees
- MOGU N/A
- AYTU N/A
- Industry
- MOGU Business Services
- AYTU Biotechnology: Pharmaceutical Preparations
- Sector
- MOGU Consumer Discretionary
- AYTU Health Care
- Exchange
- MOGU Nasdaq
- AYTU Nasdaq
- Market Cap
- MOGU 16.2M
- AYTU 15.0M
- IPO Year
- MOGU 2018
- AYTU N/A
- Fundamental
- Price
- MOGU $2.50
- AYTU $2.36
- Analyst Decision
- MOGU
- AYTU
- Analyst Count
- MOGU 0
- AYTU 0
- Target Price
- MOGU N/A
- AYTU N/A
- AVG Volume (30 Days)
- MOGU 7.6K
- AYTU 29.8K
- Earning Date
- MOGU 07-09-2024
- AYTU 11-12-2024
- Dividend Yield
- MOGU N/A
- AYTU N/A
- EPS Growth
- MOGU N/A
- AYTU N/A
- EPS
- MOGU N/A
- AYTU N/A
- Revenue
- MOGU $22,206,772.00
- AYTU $81,002,000.00
- Revenue This Year
- MOGU N/A
- AYTU N/A
- Revenue Next Year
- MOGU N/A
- AYTU N/A
- P/E Ratio
- MOGU N/A
- AYTU N/A
- Revenue Growth
- MOGU N/A
- AYTU N/A
- 52 Week Low
- MOGU $1.62
- AYTU $2.20
- 52 Week High
- MOGU $3.58
- AYTU $3.50
- Technical
- Relative Strength Index (RSI)
- MOGU 60.53
- AYTU 44.84
- Support Level
- MOGU $2.26
- AYTU $2.26
- Resistance Level
- MOGU $3.14
- AYTU $2.47
- Average True Range (ATR)
- MOGU 0.22
- AYTU 0.15
- MACD
- MOGU 0.06
- AYTU -0.01
- Stochastic Oscillator
- MOGU 47.54
- AYTU 16.10
About MOGU MOGU Inc. (each representing 25)
MOGU Inc is an online fashion and lifestyle destination in China. The company's online platform includes Mogu.com, Mogujie.com, and Meilishuo.com. Its platform allows people to discover and share fashion trends while fully enjoying the shopping experience. The company on its platform provides content related to fashion and lifestyle guides in various multi-media formats which include Live Video Broadcasts, Short-form Videos, Photography, and Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology and other relevant services to merchants and users as well as technology services to brands owners.
About AYTU Aytu BioPharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complimentary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. AR101/enzastaurin has received Orphan Drug designation from the FDA. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which it generates maximum revenue from the Rx segment.